Angiopoietin 1 Recombinant monoclonal antibody, PBS Only 81990-4-PBS proteintech

$699.00
In stock
SKU
81990-4-PBS
Catalog No.SizePrice (USD)
81990-4-PBS-100UG100 μg$699.00
Catalog Number81990-4-PBS
SynonymsANGPT1, 240764D10, AGP1, AGPT, ANG 1
HostRabbit
Reactivityhuman, mouse
FormLiquid
FormulationPBS Only
ApplicationsWB, IHC, IF-P, FC (Intra), ELISA
Host / IsotypeRabbit / IgG
Tested Reactivityhuman, mouse
ClassRecombinant
TypeAntibody
ImmunogenCatNo: Ag18829 Product name: Recombinant human ANGPT1 protein Source: e coli. -derived, PET28a Tag: 6*His Domain: 161-293 aa of BC152411 Sequence: IQLLENSLSTYKLEKQLLQQTNEILKIHEKNSLLEHKILEMEGKHKEELDTLKEEKENLQGLVTRQTYIIQELEKQLNRATTNNSVLQKQQLELMDTVHNLVNLCTKEGVLLKGGKREEEKPFRDCADVYQAG Predict reactive species
Full Nameangiopoietin 1
Calculated Molecular Weight498 aa, 58 kDa
Observed Molecular Weight70 kDa
GenBank Accession NumberBC152411
Gene SymbolAngiopoietin 1
Gene ID (NCBI)284
RRIDAB_3670511
ConjugateUnconjugated
Purification MethodProtein A purfication
UNIPROT IDQ15389
Storage BufferPBS only, pH 7.3.
Storage ConditionsStore at -80°C.
Citations-
IsotypeIgG
ClonalityRecombinant
Clone Number240764D10
ConjugationUnconjugated

Angiopoietin 1 is a 70-kDa secreted glycoprotein generated from vascular mural cells, pericytes, and certain other cells. Angiopoietin 1 participates in vascular differentiation through angiogenesis, which is the process of the growth and remodelling of existing vessels. Angiopoietin 1 is also involved in the maintenance and turnover of blood vessels in mature animals. Angiopoietin 1 binds to and activates the TEK/TIE2 receptor by inducing its dimerization and tyrosine phosphorylation, playing an important role in the regulation of angiogenesis. Overexpression of Angiopoietin 1 has been proven to occur in malignant glioblastoma, neuroblastoma, non-small cell lung cancer, and other tumors.

Reviews

Write Your Own Review
You're reviewing:Angiopoietin 1 Recombinant monoclonal antibody, PBS Only 81990-4-PBS proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.